Status:
COMPLETED
Neurocognitive Enhancement in Major Depressive Disorder
Lead Sponsor:
Queen's University
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to examine the effects of neurocognitive enhancement on cognitive abilities and related social and adaptive behaviours in individuals diagnosed with major depressive disor...
Eligibility Criteria
Inclusion
- Male or Female.
- Subjects will be between the ages of 18 and 65, which is the age range with available normative comparison data.
Exclusion
- Presence of a medical diagnosis that is associated with known cognitive impairments, such as multiple sclerosis, cerebrovascular accident, dementia, or history of traumatic brain injury.
- Subjects with a reading level below grade 6, as assessed with the Wide Range Achievement Test - Reading Recognition Subtest, will be excluded because of the likelihood of not understanding task instructions.
- Subjects with uncorrectable vision or hearing impairment that would preclude valid assessments or intervention procedures.
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT00998569
Start Date
October 1 2009
End Date
March 1 2012
Last Update
August 31 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen's University
Kingston, Ontario, Canada, K7L 3N6